2003
Morbidity and mortality in obstructive sleep apnea syndrome 1: Effect of treatment on cardiovascular morbidity
SHEPERTYCKY M, AL‐BARRAK M, KRYGER M. Morbidity and mortality in obstructive sleep apnea syndrome 1: Effect of treatment on cardiovascular morbidity. Sleep And Biological Rhythms 2003, 1: 15-28. DOI: 10.1046/j.1446-9235.2003.00003.x.Peer-Reviewed Original ResearchObstructive sleep apnea syndromeSevere cardiovascular outcomesCongestive heart failureIschemic heart diseaseCardiovascular morbidityHeart failureCardiovascular outcomesPulmonary hypertensionSystemic hypertensionHeart diseaseCardiac arrhythmiasContinuous positive airway pressure (CPAP) treatmentPositive airway pressure treatmentOngoing population-based studyLarge ongoing trialsUntreated OSAS patientsIndependent risk factorDevelopment of hypertensionEpisodes of apneaSleep apnea syndromePopulation-based studyEffect of treatmentNocturnal hypoxemiaOSA patientsOSAS patients
1999
Clinical presentations of obstructive sleep apnea syndrome
Skomro R, Kryger M. Clinical presentations of obstructive sleep apnea syndrome. Progress In Cardiovascular Diseases 1999, 41: 331-340. PMID: 10406327, DOI: 10.1053/pcad.1999.0410331.Peer-Reviewed Original ResearchConceptsObstructive sleep apnea syndromeSleep apnea syndromeQuality of lifeApnea syndromeClinical presentationTreatment of OSASClinical practiceBlood pressure controlIschemic heart diseaseHealth care professionalsMiddle-aged adultsCardiovascular morbidityPulmonary hypertensionMajor sequelaeUnderrecognized disorderCardiorespiratory failureDaytime somnolenceUpper airwayPrompt evaluationHeart diseaseRisk factorsClinical impressionNeurocognitive complaintsCare professionalsPressure control